0
0.5
1
1.5
2+
Mortality
33%
Improvement
Relative Risk
HCQ for COVID-19 Chari et al. LATE TREATMENT
Is late treatment with HCQ beneficial for COVID-19?
Retrospective 502 patients in multiple countries
Lower mortality with HCQ (not stat. sig., p=0.17)
c19hcq.org
Chari et al., Blood, December 2020
Favors HCQ
Favors control